a shared expansion pattern in these two geographically distinct groups, making it possible to understand more about the ancestry of these particular mutations that cause this disease. In another study, Mukerji and her team analyzed another heritable neural disorder, dyslexia. They identified genes of a PCDHG cluster and pinpointed specific chromosomal locations of polymorphisms that contribute to the disorder. They also tracked the mutational history and lineages of these polymorphism, in both humans and other related primates. Their work helps better explain the mechanisms in play in dyslexia and the association of PCDHG genes with "neural adhesion proteins" that are related to cognitive functionality in primates. Mukerji also studied active pulmonary tuberculosis in North Indian populations. Through a study of cytokine serum levels between patients with active tuberculosis and healthy individuals, Mukerji was able to identify five cytokine gene polymorphisms correlating to immunity against tuberculosis. Along with her other projects tracking mutational history and disease evolution, Mukerji also did work studying correlations between polymorphisms in the APOBEC3B gene and malaria susceptibility. Many versions of this gene with various insertions and deletions are found in human populations. Mukerji's study found a clear correlation between an insertion in this gene and populations with endemic levels of falciparum malaria, the most severe form of malaria, or in the genomes of descendants from such areas. Accordingly, their study also shows a strong correlation between a deletion in this gene and weakened defense against falciparum malaria. This provides direct evidence through population genetics survey that suggests that variants of the APOBEC3B have some effect on susceptibility to this form of malaria. Mukerji actively initiated the field of "Ayurgenomics", integrating the phenotyping Ayurveda principles of Indian medical system with "objective parameters of modern medicine for identifying molecular endophenotypes." She states that she wants her research to be able to "contemporize Ayurveda" by finding valid molecular backing for Ayurvedic practices and being able to use both to better preventative medical practice. Her research on SNPs and CNV diversity in the Indian population as a part of the Indian Genome Variation Consortium provided genetic evidence for Ayurvedic "Prakritis", or subgroups of healthy individuals based on phenotypic differences that govern an individual's lifestyle and medical profile. These "Prakriti's" are used for "assessing disease susceptibility and drug responsiveness", a concept that parallels ideas of personalized pharmaceuticals in Western Medicine. One molecular example Mukerji and her team studied has to go